PRESS RELEASE published on 08/27/2025 at 15:45, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc The Vanguard Group, Inc. discloses 5.38% stake in Spirent Communications plc as of 26 August 2025 The Vanguard Group, Inc. Relevant Securities Financial Disclosure Stake Disclosure Spirent Communications PLC
PRESS RELEASE published on 08/27/2025 at 15:44, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Spectris plc The Vanguard Group, Inc. discloses 5.53% ownership in Spectris plc with 5,493,480 securities. Form 8.3 filing under Rule 8.3 of the Takeover Code Securities Form 8.3 Vanguard Group Ownership Spectris Plc
BRIEF published on 08/26/2025 at 14:58, 1 year ago The Vanguard Group Discloses Position in Qualcomm Under Form 8.3 Form 8.3 The Vanguard Group Takeover Code Stock Position Qualcomm
BRIEF published on 08/26/2025 at 14:57, 1 year ago The Vanguard Group Discloses Position in American Axle & Manufacturing Form 8.3 Securities Disclosure Vanguard Group Ownership Interests American Axle
BRIEF published on 08/26/2025 at 14:57, 1 year ago The Vanguard Group Discloses Stake in Mural Oncology plc Securities Irish Takeover Panel Vanguard Group Stake Disclosure Mural Oncology
PRESS RELEASE published on 08/26/2025 at 14:53, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. filed a Form 8.3 disclosing a 10.72% stake in Qualcomm Incorporated's USD 0.0001 common shares on 25 August 2025 Form 8.3 Vanguard Group Stake Disclosure Financial Holdings Qualcomm Incorporated
PRESS RELEASE published on 08/26/2025 at 14:52, 1 year ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.43% ownership in American Axle & Manufacturing Holdings, Inc. through 8,734,180 relevant securities on 25 Aug 2025 Relevant Securities The Vanguard Group Ownership Disclosure Financial Disclosure American Axle & Manufacturing Holdings
PRESS RELEASE published on 08/26/2025 at 14:52, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 4.47% stake in Mural Oncology plc through Form 8.3. No other disclosures made. Details of ownership and positions provided Form 8.3 Vanguard Group Financial Disclosure Stake Disclosure Mural Oncology Plc
BRIEF published on 08/25/2025 at 15:36, 1 year ago The Vanguard Group Discloses Significant Position in Qualcomm Form 8.3 Securities Disclosure Vanguard Group Stakeholding Qualcomm
BRIEF published on 08/25/2025 at 15:35, 1 year ago The Vanguard Group Discloses Stake in American Axle & Manufacturing Securities Form 8.3 Disclosure Vanguard Group American Axle
Published on 09/12/2026 at 02:35, 1 day 16 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 20 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 21 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 2 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 day 1 hour ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 11 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 20 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 20 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 23 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 12 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 2 days 23 hours ago Availability of the 2026 Interim Financial Report
